Cerence Inc. SEC filings document formal disclosures for a public software company focused on conversational AI-powered user experiences. Recent 8-K filings include earnings releases and investor presentations with GAAP and non-GAAP financial measures, revenue and cash-flow disclosures, and commentary on software licensing, connected services and customer-program activity.
The filings also record shareholder meeting results, board elections, advisory compensation votes, auditor ratification, restructuring-related charges, executive compensation arrangements, and material intellectual-property matters, including patent litigation resolution and license agreements. These records frame Cerence's governance, operating costs, capital allocation and technology-rights disclosures.
On October 9, 2026, Brian M. Krzanich, Cerence Inc.'s Chief Executive Officer, reported a sale of 131,715 common shares at $8.26 per share. The shares were required to be sold to cover tax withholding obligations connected with RSU vesting under the issuer's equity-plan election; the sale was not discretionary. His direct holdings after the sale were 1,568,673 shares.
Cerence Inc. CFO Antonio Rodriquez reported selling 76,614 common shares at $8.00 per share on October 7, 2026. The sale was required to cover tax withholding obligations related to RSU vesting under the issuer’s sell-to-cover election and was not discretionary. He also reported purchasing 2,000 shares at $7.02 per share through the Employee Stock Purchase Plan on February 15, 2026. No Rule 10b5-1 plan is reported.
Cerence Inc. Chief Executive Officer Brian M. Krzanich reported selling 21,703 shares of common stock on October 7, 2026, at $8.00 per share. The sale covered tax withholding obligations connected with RSU vesting and was required under the issuer’s sell-to-cover election; it was not a discretionary trade. Krzanich directly held 1,700,388 shares after the sale. No Rule 10b5-1 plan is reported.
Cerence Inc. (CRNC) EVP, Chief Revenue Officer Christian Mentz sold 48,923 shares of common stock on October 7, 2026, at $8 per share. The shares were sold to cover tax withholding obligations tied to RSU vesting; Cerence’s equity-plan election mandated the transaction, which was not discretionary. Mentz directly held 244,551 shares after the sale.
Jennifer Salinas, Cerence Inc.’s EVP Chief Admin Officer, sold 66,153 shares of common stock at $8.00 per share on October 7, 2026. Reported direct holdings after the sale were 627,876 shares. The sale covered tax withholding obligations connected with RSU vesting and was required under Cerence’s election under its equity incentive plans; it was not a discretionary trade. No Rule 10b5-1 plan is reported.
At Cerence Inc. (CRNC), EVP Product & Technology Nils Schanz sold 52,439 shares of common stock at $8 per share on October 7, 2026, and held 290,243 shares directly after the transaction. The sale covered tax withholding obligations tied to RSU vesting and was required under the issuer’s equity incentive plans, rather than a discretionary trade. No Rule 10b5-1 plan is reported.
Cerence Inc. (CRNC) reported that on August 25, 2026 it entered into privately negotiated transactions with certain holders of its 1.50% Convertible Senior Notes due 2028.
The company agreed to repurchase $10 million aggregate principal amount of these Notes for a cash repurchase price equal to 92.75% of their principal amount, plus accrued and unpaid interest to, but not including, the settlement date. Cerence states that it intends to cancel the repurchased Notes, thereby reducing the amount of its outstanding 1.50% Convertible Senior Notes due 2028.
Cerence Inc. executive Jennifer Salinas, EVP Chief Admin Officer, reported a sale of 25,998 shares of common stock on 2026-08-10 in an open-market or private transaction. The shares were sold at a weighted average price of $8.8279 per share, with trade prices ranging from $8.675 to $8.965. Following this transaction, she directly holds 694,029 shares of Cerence common stock.
A holder of 25,998 shares of CRNC common stock has filed to potentially sell these shares through Morgan Stanley Smith Barney LLC Executive Financial Services. The planned transaction has an aggregate market value of $229,507.74 and lists an approximate sale date of August 10, 2026 on NASDAQ.
The filing also references prior acquisitions of CRNC restricted stock from the issuer on October 1, 2025, covering grants of 2,753 and 23,245 shares.